Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

American Funds American Mutual A

Capital Group American Mutual Comp

Capital Group Investment Co of Amer Comp

American Funds Invmt Co of Amer A

Vanguard Dividend Appreciation ETF

American Funds Income Fund of Amer A

First Eagle Global A

American Funds Capital Income Bldr A

State St S&P 500® Indx SL Cl III

Vanguard High Dividend Yield ETF

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

iShares Core S&P 500 ETF

Vanguard Value Index Inv

Vanguard Dividend Growth Inv

The Health Care Select Sector SPDR® ETF

Vanguard Windsor™ II Inv

Vanguard Institutional Index I

Vanguard Group Inc

BlackRock Inc

Wellington Management Company LLP

Deutsche Bank AG

Franklin Resources Inc

NORGES BANK

Amvescap Plc.

Legal & General Group PLC

Royal Bank of Canada

Ameriprise Financial Inc

Northern Trust Corp

Arnhold & S. Bleichroeder Advisers, LLC

State Street Corp

Capital Research Global Investors

JPMorgan Chase & Co

Geode Capital Management, LLC

Massachusetts Financial Services Company

Morgan Stanley - Brokerage Accounts

Bank of America Corp

Bank of New York Mellon Corp

Medtronic PLC

Mr. Geoffrey Straub Martha

Chairman of the Board & CEO

Mr. Sean M. Salmon

Executive VP & President of Cardiovascular Portfolio

Mr. Brett A. Wall

Executive VP & President of Neuroscience Portfolio

Mr. Gregory L. Smith

Executive Vice President of Global Operations & Supply Chain

Gary  Corona

Senior Vice President of Global Financial Planning and Analysis & Interim CFO

Mr. Mark  Ploof

Senior Vice President of Global Operations and Business Services

Ms. Jennifer M. Kirk

Senior VP, Global Controller & Chief Accounting Officer

Dr. Kenneth E. Washington Ph.D.

Senior VP and Chief Technology & Innovation Officer

Dr. Laura  Mauri M.D., M.Sc.

Senior VP and Chief Scientific & Medical Officer

Mr. Ryan  Weispfenning

VP & Head of Investor Relations

MDT's next earnings is on February 18, 2025 (Before Market Open)

MDT's latest dividend is 0.7 USD on September 27, 2024

Medtronic PLC (MDT) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Medtronic PLC (MDT) Earnings Report Date and History | NYSE

MDT's next earnings is on February 18, 2025 (Before Market Open)

When is the earnings report for MDT?

MDT Earnings History

MDT's latest dividend is 0.7 USD on September 27, 2024

MDT Stock Discussion Forum and Message Board

News for NYSE: MDT